查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1509672

醫藥品用明膠的全球市場的評估:各類型，來源，各用途，各功能，各終端用戶，各地區，機會，預測(2017年～2031年)

Pharmaceutical Gelatin Market Assessment, By Type, By Source, By Application, By Function, By End-user, By Region, Opportunities and Forecast, 2017-2031F
出版日期: | 出版商: Market Xcel - Markets and Data | 英文 228 Pages | 商品交期: 3-5個工作天內

價格

全球藥用明膠市場規模預計將從 2023 年的 12.5 億美元增至 2031 年的 19.2 億美元，在 2024-2031 年預測期內複合年增長率預計為 5.57%。塑造市場的因素有很多。其中包括研究投資的增加、技術的進步、對豬肉明膠的高需求、明膠膠囊的日益普及、歐洲市場需求的增加以及尋求擴張機會的公司。

市場的關鍵驅動因素之一是研發策略投資的增加。這些策略有助於促進成長和增加產量所需的工業創新和技術進步。隨著藥物傳輸和基於明膠的治療技術的進步，明膠正在尋找新的醫學用途。對豬肉明膠的高需求也是全球藥用明膠市場的主要成長動力。豬肉明膠的優良品質使其非常適合用於製藥業。隨著技術的進步，豬肉明膠的用途不斷增加，這表明未來對該產品的需求將持續下去。

膠囊技術的進步，例如植物基明膠膠囊的誕生，提高了明膠膠囊的性能和適應性，使其對生產商和客戶都更具吸引力。明膠膠囊在全球藥用明膠市場的需求量很大，因為它們能夠保護內容物免受空氣、光線、微生物生長和污染的影響。歐洲市場也是全球市場的主要成長動力。隨著歐盟 (EU) 醫藥市場的成長和醫藥產業的強勁，藥用明膠變得越來越重要。

最後，公司正在尋求多樣性和成長。新明膠品牌的推出以及現有品牌在新領域的發展清楚地證明了這一點。預計這些因素將在未來幾年推動全球藥用明膠市場的進一步成長和多元化。

例如，2024 年5 月，喀拉拉邦工業發展有限公司(KSIDC) 和日本Nitta Gelatin Inc. 日本透過Nitta Gelatin India Ltd (NGIL) 在喀拉拉邦聯合啟動了一個耗資718 萬美元的擴建項目。該項目是喀拉拉邦首席部長最近訪問日本期間這家日本跨國公司宣布的 2,396 萬美元投資的一部分。

研究活動支持市場擴張

由於產業研發 (R&D) 活動的增加，全球藥用明膠市場正在大規模擴張。製藥公司投資數百萬美元用於研發，以開發尖端的明膠產品，例如可生物降解膠囊和先進的藥物傳輸系統。因此，新的明膠品牌和產品不斷湧現，例如 X-Pure-GelDAT，它是 GelTYR-明膠酪胺的替代品。此外，明膠生產方法的發展預計將提高生產力和可用性，並推動全球藥用明膠市場的擴張。

例如，2022 年 1 月，Darling Ingredients Inc. 透過其膠原蛋白解決方案的全球領導者 Rousselot Health 品牌與位於加州的再生醫學研究所 Terasaki Institute for Biomedical Innovation (TBI) 合作。透過這個策略聯盟，羅賽洛和 TIBI 將共同致力於明膠療法的開發及其臨床應用。羅賽洛將向 TIBI 提供 X-Pure 改性明膠，包括 X-Pure GelMA，以換取有關明膠如何透過實驗室和臨床試驗發揮作用的資訊。

技術進步刺激市場成長

奈米技術、3D 列印、人工智慧和機器學習等技術進步正在推動全球藥用明膠市場的成長。製藥公司正在利用這些技術來生產新型明膠產品，其功能和品質超越了傳統解決方案。這些技術使明膠產品的開發過程更具成本效益和效率。明膠也廣泛應用於其他製藥領域，如基因治療、藥物傳輸系統和組織工程。由於這些技術正在推動全球藥用明膠市場的成長，明膠在製藥業的使用預計將繼續擴大。

本報告提供全球醫藥品用明膠市場相關調查分析，提供市場規模與預測，市場動態，主要企業的形勢及預測等資訊。

目錄

第1章 調查手法

第2章 計劃的範圍和定義

第3章 摘要整理

第4章 全球醫藥品用明膠市場預測(2017年～2031年)

  • 市場規模與預測
    • 金額
    • 數量
  • 各類型
    • A類型
    • B類型
  • 來源
    • 牛
    • 豬
    • 其他
  • 各用途
    • 硬明膠膠囊
    • 軟體明膠膠囊
    • 其他
  • 各功能
    • 穩定化
    • 增加粘性
    • 凝膠化
    • 其他
  • 各終端用戶
    • 製藥企業
    • 生物科技企業
    • 學術·研究機關
  • 各地區
    • 北美
    • 歐洲
    • 亞太地區
    • 南美
    • 中東·非洲
  • 市場佔有率:各企業(2023年)

第5章 全球醫藥品用明膠市場預測:各地區(2017年～2031年)

  • 北美
    • 市場規模與預測
    • 各類型
    • 來源
    • 各用途
    • 各功能
    • 各終端用戶
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 法國
    • 義大利
    • 英國
    • 俄羅斯
    • 荷蘭
    • 西班牙
    • 土耳其
    • 波蘭
  • 亞太地區
    • 印度
    • 中國
    • 日本
    • 澳洲
    • 越南
    • 韓國
    • 印尼
    • 菲律賓
  • 南美
    • 巴西
    • 阿根廷
  • 中東·非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第6章 市場製圖(2023年)

  • 各類型
  • 來源
  • 各用途
  • 各功能
  • 各終端用戶
  • 各地區

第7章 宏觀環境和產業結構

  • 供需分析
  • 進口出口分析
  • 價值鏈分析
  • PESTEL分析
  • 波特的五力分析

第8章 市場動態

  • 成長促進因素
  • 阻礙成長的要素(課題，阻礙因素)

第9章 法規結構和革新

  • 專利形勢
  • 法規當局的認證
  • 革新/新技術

第10章 主要企業的形勢

  • 市場領導者前五名公司的競爭矩陣
  • 市場領導者前五名公司的市場收益的分析(2023年)
  • 合併和收購/合資企業(如果適用)
  • SWOT分析(市場5企業)
  • 專利分析(如果適用)

第11章 價格分析

第12章 案例研究

第13章 主要企業預測

  • Gelita AG
  • Darling Ingredients Inc.
  • Nitta Gelatin, Inc.
  • Tessenderlo Group
  • Weishardt International
  • Lonza Group AG
  • Aspire Pharmaceuticals, Inc.
  • Junca Gelatines S.L
  • Gelco International
  • Trobas Gelatine BV

第14章 策略性推薦

第15章 本公司相關資料，免責聲明

Product Code: MX11553

Global pharmaceutical gelatin market is projected to witness a CAGR of 5.57% during the forecast period 2024-2031F, growing from USD 1.25 billion in 2023 to USD 1.92 billion in 2031F. Various factors shape the global pharmaceutical gelatin market. These include increased investments in research, technological advancements, high demand for porcine gelatin, rise in the popularity of gelatin capsules, growing demand in the European market, and companies increasingly seeking expansion opportunities.

One significant driver of the global pharmaceutical gelatin market is the increased investment in research and development initiatives. These initiatives aid in promoting innovation and technological advancements in the industry, which is required for growth and increased production. Gelatin is finding new uses in pharmaceuticals thanks to technological developments in drug delivery and gelatin-based therapeutics. The high demand for porcine gelatin is another major factor driving the growth of the global pharmaceutical gelatin market. The superior qualities of porcine gelatin make it extremely desirable for use in the pharmaceutical industry. The applications of porcine gelatin are increasing with advancements in technologies, which indicates its continued demand for the product in the future.

Advancements are improving the performance and adaptability of gelatin capsules in capsule technology, such as the creation of plant-based gelatin capsules, which is increasing their appeal to both producers and customers. Gelatin capsules are in high demand in the global pharmaceutical gelatin market because of their ability to protect the contents from air, light, microbial growth and contamination. The European market is an additional significant factor boosting the growth of the global pharmaceutical gelatin market. Pharmaceutical gelatin is becoming more and more essential due to the European Union's growing pharmaceutical market and strong pharmaceutical sector.

Finally, businesses seek variety and growth. The introduction of new gelatin brands and the growth of established ones into new areas are clear indications of this. These factors are anticipated to fuel the further growth and diversification of the global pharmaceutical gelatin market in the upcoming years.

For example, in May 2024, the Kerala State Industrial Development Corporation Ltd (KSIDC) and Nitta Gelatin Inc. Japan jointly launched an expansion project in Kerala valued at USD 7.18 million through Nitta Gelatin India Ltd (NGIL). This project is a portion of the USD 23.96 million investment that the Japanese MNC disclosed during the Kerala Chief Minister's most recent visit to Japan.

Research Initiatives Propel the Expansion of the Market

Due to the industry's growing research and development (R&D) activities, the global pharmaceutical gelatin market is expanding significantly on a large scale. Pharmaceutical corporations are heavily spending on research and development to create cutting-edge gelatin-based products like biodegradable capsules and sophisticated drug delivery systems. New gelatin brands and products have emerged as a result, such as X-Pure-GelDAT, a substitute for GelTYR-Gelatin Tyramine. Furthermore, it is anticipated that developments in gelatin production methods will boost productivity and affordability, propelling the expansion of the global pharmaceutical gelatin market.

For example, in January 2022, Darling Ingredients Inc. established a partnership with the Terasaki Institute for Biomedical Innovation (TIBI), a regenerative medicine research institute situated in California, through its Rousselot Health brand, which is the world leader in collagen-based solutions. Rousselot and TIBI will work together on the creation of gelatin-based treatments and their clinical application through this strategic alliance. Rousselot will provide TIBI with X-Pure modified gelatins, including X-Pure GelMA, in exchange for information on how gelatin behaves in the laboratory and throughout clinical trials.

Technological Advancements Spur Growth of the Market

Advancements in technologies such as nanotechnology, 3D printing, artificial intelligence, and machine learning are propelling the growth of the global pharmaceutical gelatin market. Pharmaceutical companies are making use of these technologies to produce novel gelatin-based goods that surpass the functionality and quality of conventional solutions. These technologies have made the development process of gelatin-based products more cost-effective and efficient. Gelatin is also being extensively used in other pharmaceutical sectors such as gene therapy, drug delivery systems, and tissue engineering. The application of gelatin in the pharmaceutical industry will continue to expand due to these technologies propelling the growth of the global pharmaceutical gelatin market.

For example, in December 2023, the health brand Rousselot from Darling Ingredients Inc. announced that it had received US Patent and Trademark Office (USPTO) Patent No. US11795489B2, securing its intellectual property rights for StabiCaps, a specialized gelatin that enhances the stability and formulation of soft gel capsules to improve drugs' release.

High Demand for Porcine Gelatin Drives Market Growth

Due to the unique characteristics of gel-forming ability and the biocompatible nature of porcine gelatin, it is commonly used in the pharmaceutical industry, bolstering the growth of the global pharmaceutical gelatin market. Porcine gelatin is known for its clarity and flexibility, which makes it excessively useful in the manufacturing of hard gelatin capsules, and it also has other applications in the pharmaceutical industry, such as soft capsules, absorbable hemostats, etc. It is also used as a stabilizer in vaccines to preserve its efficacy and safety throughout the transit and storage process. Porcine gelatin is a preferred choice for pharmaceutical manufacturers because of its ease of production, nutritious content, and reduced cost.

For instance, to save production costs and waste related to soft gel leakers, Gelita AG, a global leader in gelatin, introduced Easyseal gelatin in December 2023. The novel solution can be obtained in swine form that complies with food and drug administration (FDA) requirements, and a corresponding China Drug Masterfile is available to facilitate entry into the Chinese market.

Rise in the Popularity of Gelatin Capsules Fuels Market Growth

There is a huge demand for gelatin capsules because of their versatility and ease of use. A significant demand for dietary supplements and nutraceuticals has been seen in the last few years, boosting the growth of gelatin capsules in the global pharmaceutical gelatin market. There is an increased demand for gelatin capsules made from alternative sources because of the rise in inclination towards vegan lifestyles and plant-based food. Gelatin capsules are becoming more customizable and effective due to technological and formulation advances, which appeal to both manufacturers and consumers.

In September 2023, Strides Pharma Science Limited declared that the United States Food and Drug Administration (USFDA) has approved Icosapent Ethyl Capsules, 0.5 gram and 1 gram, through its step-down wholly owned subsidiary, Strides Pharma Global Pte, Singapore. The product enhances the selection of authorized soft gelatin capsules offered by Strides.

Europe Shows Dominance in the Pharmaceutical Gelatin Market

Europe's pharmaceutical gelatin market has observed significant growth over the past couple of years. Companies are focusing on producing new products through research and development to cater to the growing demand that has arisen because of the growing burden of chronic diseases and the rise in the geriatric population. The global pharmaceutical gelatin market participants focus on continuous clinical trials to improve the efficacy of the medications. The global pharmaceutical gelatin market is expanding due to pharmaceutical companies and concerned authorities meeting patient requirements, surpassing challenges such as the limitations of sustainability and ethical concerns.

For example, Caldic B.V. and Nitta Gelatin, Inc. announced that they had reached an agreement to form a strategic distribution relationship in Europe. Through this partnership, Caldic will be able to provide a greater selection of specialty gelatin products and a broad range of collagen products that perfectly match its current line of products for the Food, Nutrition, Pharma, and Personal Care markets. Starting on January 1, 2024, Caldic and Nitta Gelatin collaborated to create prospects in Benelux, France, Iberia, Italy, Germany, Austria, Switzerland, United Kingdom, and Ireland.

Future Market Scenario (2024-2031F)

The significant shift toward biodegradable gelatin capsules is considered a major factor driving the growth of the global pharmaceutical gelatin market in the future.

The global pharmaceutical gelatin market will witness a significant rise in the use of gelatin in the functional food industry.

Advanced technologies like nanotechnology and 3D printing are going to drive the global pharmaceutical gelatin market. These technologies are used to produce innovative gelatin products with enhanced properties.

An increased use of gelatin in cosmetics and personal care products is expected to significantly drive the growth of the global pharmaceutical gelatin market.

Key Players Landscape and Outlook

One of the main factors driving the expansion of the global pharmaceutical gelatin market is partnerships and collaborations. These partnerships guarantee that many viewpoints are considered to meet the needs of a diversified nature. Through successful collaborations, companies in the industry share their expertise in developing new and innovative solutions, increasing efficiency, and reducing costs. Companies also often collaborate to increase their expansion in the global pharmaceutical gelatin market and reach new customers.

For example, in March 2024, BIO INX B.V., a leading material developer for 3D bioprinting, announced a strategic relationship with Rousselot GmbH, a global leader in gelatin- and collagen-based solutions included in Darling Ingredients Inc. This partnership represents a significant advancement in the field of 3D bioprinting. As part of this partnership, Rousselot's X-Pure gelatin biomaterials, which are known for their dependability and quality, will be distributed by BIO INX for research and technical purposes.

Table of Contents

1. Research Methodology

2. Project Scope and Definitions

3. Executive Summary

4. Global Pharmaceutical Gelatin Market Outlook, 2017-2031F

  • 4.1. Market Size & Forecast
    • 4.1.1. By Value
    • 4.1.2. By Volume
  • 4.2. By Type
    • 4.2.1. Type A
    • 4.2.2. Type B
  • 4.3. By Source
    • 4.3.1. Bovine
    • 4.3.2. Porcine
    • 4.3.3. Others
  • 4.4. By Application
    • 4.4.1. Hard Gelatin Capsules
    • 4.4.2. Soft Gelatin Capsules
    • 4.4.3. Others
  • 4.5. By Function
    • 4.5.1. Stabilizing
    • 4.5.2. Thickening
    • 4.5.3. Gelling
    • 4.5.4. Others
  • 4.6. By End-user
    • 4.6.1. Pharmaceutical Companies
    • 4.6.2. Biotechnology Companies
    • 4.6.3. Academic and Research Institutions
  • 4.7. By Region
    • 4.7.1. North America
    • 4.7.2. Europe
    • 4.7.3. Asia-Pacific
    • 4.7.4. South America
    • 4.7.5. Middle East and Africa
  • 4.8. By Company Market Share (%), 2023

5. Global Pharmaceutical Gelatin Market Outlook, By Region, 2017-2031F

  • 5.1. North America*
    • 5.1.1. Market Size & Forecast
      • 5.1.1.1. By Value
      • 5.1.1.2. By Volume
    • 5.1.2. By Type
      • 5.1.2.1. Type A
      • 5.1.2.2. Type B
    • 5.1.3. By Source
      • 5.1.3.1. Bovine
      • 5.1.3.2. Porcine
      • 5.1.3.3. Others
    • 5.1.4. By Application
      • 5.1.4.1. Hard Gelatin Capsules
      • 5.1.4.2. Soft Gelatin Capsules
      • 5.1.4.3. Others
    • 5.1.5. By Function
      • 5.1.5.1. Stabilizing
      • 5.1.5.2. Thickening
      • 5.1.5.3. Gelling
      • 5.1.5.4. Others
    • 5.1.6. By End-user
      • 5.1.6.1. Pharmaceutical Companies
      • 5.1.6.2. Biotechnology Companies
      • 5.1.6.3. Academic and Research Institutions
    • 5.1.7. United States*
      • 5.1.7.1. Market Size & Forecast
        • 5.1.7.1.1. By Value
        • 5.1.7.1.2. By Volume
      • 5.1.7.2. By Type
        • 5.1.7.2.1. Type A
        • 5.1.7.2.2. Type B
      • 5.1.7.3. By Source
        • 5.1.7.3.1. Bovine
        • 5.1.7.3.2. Porcine
        • 5.1.7.3.3. Others
      • 5.1.7.4. By Application
        • 5.1.7.4.1. Hard Gelatin Capsules
        • 5.1.7.4.2. Soft Gelatin Capsules
        • 5.1.7.4.3. Others
      • 5.1.7.5. By Function
        • 5.1.7.5.1. Stabilizing
        • 5.1.7.5.2. Thickening
        • 5.1.7.5.3. Gelling
        • 5.1.7.5.4. Others
      • 5.1.7.6. By End-user
        • 5.1.7.6.1. Pharmaceutical Companies
        • 5.1.7.6.2. Biotechnology Companies
        • 5.1.7.6.3. Academic and Research Institutions
    • 5.1.8. Canada
    • 5.1.9. Mexico

All segments will be provided for all regions and countries covered

  • 5.2. Europe
    • 5.2.1. Germany
    • 5.2.2. France
    • 5.2.3. Italy
    • 5.2.4. United Kingdom
    • 5.2.5. Russia
    • 5.2.6. Netherlands
    • 5.2.7. Spain
    • 5.2.8. Turkey
    • 5.2.9. Poland
  • 5.3. Asia-Pacific
    • 5.3.1. India
    • 5.3.2. China
    • 5.3.3. Japan
    • 5.3.4. Australia
    • 5.3.5. Vietnam
    • 5.3.6. South Korea
    • 5.3.7. Indonesia
    • 5.3.8. Philippines
  • 5.4. South America
    • 5.4.1. Brazil
    • 5.4.2. Argentina
  • 5.5. Middle East and Africa
    • 5.5.1. Saudi Arabia
    • 5.5.2. UAE
    • 5.5.3. South Africa

6. Market Mapping, 2023

  • 6.1. By Type
  • 6.2. By Source
  • 6.3. By Application
  • 6.4. By Function
  • 6.5. By End-user
  • 6.6. By Region

7. Macro Environment and Industry Structure

  • 7.1. Demand Supply Analysis
  • 7.2. Import Export Analysis
  • 7.3. Value Chain Analysis
  • 7.4. PESTEL Analysis
    • 7.4.1. Political Factors
    • 7.4.2. Economic System
    • 7.4.3. Social Implications
    • 7.4.4. Technological Advancements
    • 7.4.5. Environmental Impacts
    • 7.4.6. Legal Compliances and Regulatory Policies (Statutory Bodies Included)
  • 7.5. Porter's Five Forces Analysis
    • 7.5.1. Supplier Power
    • 7.5.2. Buyer Power
    • 7.5.3. Substitution Threat
    • 7.5.4. Threat From New Entrant
    • 7.5.5. Competitive Rivalry

8. Market Dynamics

  • 8.1. Growth Drivers
  • 8.2. Growth Inhibitors (Challenges and Restraints)

9. Regulatory Framework and Innovation

  • 9.1. Patent Landscape
  • 9.2. Regulatory Approvals
  • 9.3. Innovations/Emerging Technologies

10. Key Players Landscape

  • 10.1. Competition Matrix of Top Five Market Leaders
  • 10.2. Market Revenue Analysis of Top Five Market Leaders (By Value, 2023)
  • 10.3. Mergers and Acquisitions/Joint Ventures (If Applicable)
  • 10.4. SWOT Analysis (For Five Market Players)
  • 10.5. Patent Analysis (If Applicable)

11. Pricing Analysis

12. Case Studies

13. Key Players Outlook

  • 13.1. Gelita AG
    • 13.1.1. Company Details
    • 13.1.2. Key Management Personnel
    • 13.1.3. Products and Services
    • 13.1.4. Financials (As Reported)
    • 13.1.5. Key Market Focus and Geographical Presence
    • 13.1.6. Recent Developments
  • 13.2. Darling Ingredients Inc.
  • 13.3. Nitta Gelatin, Inc.
  • 13.4. Tessenderlo Group
  • 13.5. Weishardt International
  • 13.6. Lonza Group AG
  • 13.7. Aspire Pharmaceuticals, Inc.
  • 13.8. Junca Gelatines S.L
  • 13.9. Gelco International
  • 13.10. Trobas Gelatine BV

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

14. Strategic Recommendations

15. About Us & Disclaimer

List of Tables

  • Table 1. Pricing Analysis of Products from Key Players
  • Table 2. Competition Matrix of Top 5 Market Leaders
  • Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
  • Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

  • Figure 1. Global Pharmaceutical Gelatin Market, By Value, In USD Billion, 2017-2031F
  • Figure 2. Global Pharmaceutical Gelatin Market, By Volume, In Billion Units, 2017-2031F
  • Figure 3. Global Pharmaceutical Gelatin Market Share (%), By Type, 2017-2031F
  • Figure 4. Global Pharmaceutical Gelatin Market Share (%), By Source, 2017-2031F
  • Figure 5. Global Pharmaceutical Gelatin Market Share (%), By Application, 2017-2031F
  • Figure 6. Global Pharmaceutical Gelatin Market Share (%), By Function, 2017-2031F
  • Figure 7. Global Pharmaceutical Gelatin Market Share (%), By End-User, 2017-2031F
  • Figure 8. Global Pharmaceutical Gelatin Market Share (%), By Region, 2017-2031F
  • Figure 9. North America Pharmaceutical Gelatin Market, By Value, In USD Billion, 2017-2031F
  • Figure 10. North America Pharmaceutical Gelatin Market, By Volume, In Billion Units, 2017-2031F
  • Figure 11. North America Pharmaceutical Gelatin Market Share (%), By Type, 2017-2031F
  • Figure 12. North America Pharmaceutical Gelatin Market Share (%), By Source, 2017-2031F
  • Figure 13. North America Pharmaceutical Gelatin Market Share (%), By Application, 2017-2031F
  • Figure 14. North America Pharmaceutical Gelatin Market Share (%), By Function, 2017-2031F
  • Figure 15. North America Pharmaceutical Gelatin Market Share (%), By End-User, 2017-2031F
  • Figure 16. North America Pharmaceutical Gelatin Market Share (%), By Country, 2017-2031F
  • Figure 17. United States Pharmaceutical Gelatin Market, By Value, In USD Billion, 2017-2031F
  • Figure 18. United States Pharmaceutical Gelatin Market, By Volume, In Billion Units, 2017-2031F
  • Figure 19. United States Pharmaceutical Gelatin Market Share (%), By Type, 2017-2031F
  • Figure 20. United States Pharmaceutical Gelatin Market Share (%), By Source, 2017-2031F
  • Figure 21. United States Pharmaceutical Gelatin Market Share (%), By Application, 2017-2031F
  • Figure 22. United States Pharmaceutical Gelatin Market Share (%), By Function, 2017-2031F
  • Figure 23. United States Pharmaceutical Gelatin Market Share (%), By End-User, 2017-2031F
  • Figure 24. Canada Pharmaceutical Gelatin Market, By Value, In USD Billion, 2017-2031F
  • Figure 25. Canada Pharmaceutical Gelatin Market, By Volume, In Billion Units, 2017-2031F
  • Figure 26. Canada Pharmaceutical Gelatin Market Share (%), By Type, 2017-2031F
  • Figure 27. Canada Pharmaceutical Gelatin Market Share (%), By Source, 2017-2031F
  • Figure 28. Canada Pharmaceutical Gelatin Market Share (%), By Application, 2017-2031F
  • Figure 29. Canada Pharmaceutical Gelatin Market Share (%), By Function, 2017-2031F
  • Figure 30. Canada Pharmaceutical Gelatin Market Share (%), By End-User, 2017-2031F
  • Figure 31. Mexico Pharmaceutical Gelatin Market, By Value, In USD Billion, 2017-2031F
  • Figure 32. Mexico Pharmaceutical Gelatin Market, By Volume, In Billion Units, 2017-2031F
  • Figure 33. Mexico Pharmaceutical Gelatin Market Share (%), By Type, 2017-2031F
  • Figure 34. Mexico Pharmaceutical Gelatin Market Share (%), By Source, 2017-2031F
  • Figure 35. Mexico Pharmaceutical Gelatin Market Share (%), By Application, 2017-2031F
  • Figure 36. Mexico Pharmaceutical Gelatin Market Share (%), By Function, 2017-2031F
  • Figure 37. Mexico Pharmaceutical Gelatin Market Share (%), By End-User, 2017-2031F
  • Figure 38. Europe Pharmaceutical Gelatin Market, By Value, In USD Billion, 2017-2031F
  • Figure 39. Europe Pharmaceutical Gelatin Market, By Volume, In Billion Units, 2017-2031F
  • Figure 40. Europe Pharmaceutical Gelatin Market Share (%), By Type, 2017-2031F
  • Figure 41. Europe Pharmaceutical Gelatin Market Share (%), By Source, 2017-2031F
  • Figure 42. Europe Pharmaceutical Gelatin Market Share (%), By Application, 2017-2031F
  • Figure 43. Europe Pharmaceutical Gelatin Market Share (%), By Function, 2017-2031F
  • Figure 44. Europe Pharmaceutical Gelatin Market Share (%), By End-User, 2017-2031F
  • Figure 45. Europe Pharmaceutical Gelatin Market Share (%), By Country, 2017-2031F
  • Figure 46. Germany Pharmaceutical Gelatin Market, By Value, In USD Billion, 2017-2031F
  • Figure 47. Germany Pharmaceutical Gelatin Market, By Volume, In Billion Units, 2017-2031F
  • Figure 48. Germany Pharmaceutical Gelatin Market Share (%), By Type, 2017-2031F
  • Figure 49. Germany Pharmaceutical Gelatin Market Share (%), By Source, 2017-2031F
  • Figure 50. Germany Pharmaceutical Gelatin Market Share (%), By Application, 2017-2031F
  • Figure 51. Germany Pharmaceutical Gelatin Market Share (%), By Function, 2017-2031F
  • Figure 52. Germany Pharmaceutical Gelatin Market Share (%), By End-User, 2017-2031F
  • Figure 53. France Pharmaceutical Gelatin Market, By Value, In USD Billion, 2017-2031F
  • Figure 54. France Pharmaceutical Gelatin Market, By Volume, In Billion Units, 2017-2031F
  • Figure 55. France Pharmaceutical Gelatin Market Share (%), By Type, 2017-2031F
  • Figure 56. France Pharmaceutical Gelatin Market Share (%), By Source, 2017-2031F
  • Figure 57. France Pharmaceutical Gelatin Market Share (%), By Application, 2017-2031F
  • Figure 58. France Pharmaceutical Gelatin Market Share (%), By Function, 2017-2031F
  • Figure 59. France Pharmaceutical Gelatin Market Share (%), By End-User, 2017-2031F
  • Figure 60. Italy Pharmaceutical Gelatin Market, By Value, In USD Billion, 2017-2031F
  • Figure 61. Italy Pharmaceutical Gelatin Market, By Volume, In Billion Units, 2017-2031F
  • Figure 62. Italy Pharmaceutical Gelatin Market Share (%), By Type, 2017-2031F
  • Figure 63. Italy Pharmaceutical Gelatin Market Share (%), By Source, 2017-2031F
  • Figure 64. Italy Pharmaceutical Gelatin Market Share (%), By Application, 2017-2031F
  • Figure 65. Italy Pharmaceutical Gelatin Market Share (%), By Function, 2017-2031F
  • Figure 66. Italy Pharmaceutical Gelatin Market Share (%), By End-User, 2017-2031F
  • Figure 67. United Kingdom Pharmaceutical Gelatin Market, By Value, In USD Billion, 2017-2031F
  • Figure 68. United Kingdom Pharmaceutical Gelatin Market, By Volume, In Billion Units, 2017-2031F
  • Figure 69. United Kingdom Pharmaceutical Gelatin Market Share (%), By Type, 2017-2031F
  • Figure 70. United Kingdom Pharmaceutical Gelatin Market Share (%), By Source, 2017-2031F
  • Figure 71. United Kingdom Pharmaceutical Gelatin Market Share (%), By Application, 2017-2031F
  • Figure 72. United Kingdom Pharmaceutical Gelatin Market Share (%), By Function, 2017-2031F
  • Figure 73. United Kingdom Pharmaceutical Gelatin Market Share (%), By End-User, 2017-2031F
  • Figure 74. Russia Pharmaceutical Gelatin Market, By Value, In USD Billion, 2017-2031F
  • Figure 75. Russia Pharmaceutical Gelatin Market, By Volume, In Billion Units, 2017-2031F
  • Figure 76. Russia Pharmaceutical Gelatin Market Share (%), By Type, 2017-2031F
  • Figure 77. Russia Pharmaceutical Gelatin Market Share (%), By Source, 2017-2031F
  • Figure 78. Russia Pharmaceutical Gelatin Market Share (%), By Application, 2017-2031F
  • Figure 79. Russia Pharmaceutical Gelatin Market Share (%), By Function, 2017-2031F
  • Figure 80. Russia Pharmaceutical Gelatin Market Share (%), By End-User, 2017-2031F
  • Figure 81. Netherlands Pharmaceutical Gelatin Market, By Value, In USD Billion, 2017-2031F
  • Figure 82. Netherlands Pharmaceutical Gelatin Market, By Volume, In Billion Units, 2017-2031F
  • Figure 83. Netherlands Pharmaceutical Gelatin Market Share (%), By Type, 2017-2031F
  • Figure 84. Netherlands Pharmaceutical Gelatin Market Share (%), By Source, 2017-2031F
  • Figure 85. Netherlands Pharmaceutical Gelatin Market Share (%), By Application, 2017-2031F
  • Figure 86. Netherlands Pharmaceutical Gelatin Market Share (%), By Function, 2017-2031F
  • Figure 87. Netherlands Pharmaceutical Gelatin Market Share (%), By End-User, 2017-2031F
  • Figure 88. Spain Pharmaceutical Gelatin Market, By Value, In USD Billion, 2017-2031F
  • Figure 89. Spain Pharmaceutical Gelatin Market, By Volume, In Billion Units, 2017-2031F
  • Figure 90. Spain Pharmaceutical Gelatin Market Share (%), By Type, 2017-2031F
  • Figure 91. Spain Pharmaceutical Gelatin Market Share (%), By Source, 2017-2031F
  • Figure 92. Spain Pharmaceutical Gelatin Market Share (%), By Application, 2017-2031F
  • Figure 93. Spain Pharmaceutical Gelatin Market Share (%), By Function, 2017-2031F
  • Figure 94. Spain Pharmaceutical Gelatin Market Share (%), By End-User, 2017-2031F
  • Figure 95. Turkey Pharmaceutical Gelatin Market, By Value, In USD Billion, 2017-2031F
  • Figure 96. Turkey Pharmaceutical Gelatin Market, By Volume, In Billion Units, 2017-2031F
  • Figure 97. Turkey Pharmaceutical Gelatin Market Share (%), By Type, 2017-2031F
  • Figure 98. Turkey Pharmaceutical Gelatin Market Share (%), By Source, 2017-2031F
  • Figure 99. Turkey Pharmaceutical Gelatin Market Share (%), By Application, 2017-2031F
  • Figure 100. Turkey Pharmaceutical Gelatin Market Share (%), By Function, 2017-2031F
  • Figure 101. Turkey Pharmaceutical Gelatin Market Share (%), By End-User, 2017-2031F
  • Figure 102. Poland Pharmaceutical Gelatin Market, By Value, In USD Billion, 2017-2031F
  • Figure 103. Poland Pharmaceutical Gelatin Market, By Volume, In Billion Units, 2017-2031F
  • Figure 104. Poland Pharmaceutical Gelatin Market Share (%), By Type, 2017-2031F
  • Figure 105. Poland Pharmaceutical Gelatin Market Share (%), By Source, 2017-2031F
  • Figure 106. Poland Pharmaceutical Gelatin Market Share (%), By Application, 2017-2031F
  • Figure 107. Poland Pharmaceutical Gelatin Market Share (%), By Function, 2017-2031F
  • Figure 108. Poland Pharmaceutical Gelatin Market Share (%), By End-User, 2017-2031F
  • Figure 109. South America Pharmaceutical Gelatin Market, By Value, In USD Billion, 2017-2031F
  • Figure 110. South America Pharmaceutical Gelatin Market, By Volume, In Billion Units, 2017-2031F
  • Figure 111. South America Pharmaceutical Gelatin Market Share (%), By Type, 2017-2031F
  • Figure 112. South America Pharmaceutical Gelatin Market Share (%), By Source, 2017-2031F
  • Figure 113. South America Pharmaceutical Gelatin Market Share (%), By Application, 2017-2031F
  • Figure 114. South America Pharmaceutical Gelatin Market Share (%), By Function, 2017-2031F
  • Figure 115. South America Pharmaceutical Gelatin Market Share (%), By End-User, 2017-2031F
  • Figure 116. South America Pharmaceutical Gelatin Market Share (%), By Country, 2017-2031F
  • Figure 117. Brazil Pharmaceutical Gelatin Market, By Value, In USD Billion, 2017-2031F
  • Figure 118. Brazil Pharmaceutical Gelatin Market, By Volume, In Billion Units, 2017-2031F
  • Figure 119. Brazil Pharmaceutical Gelatin Market Share (%), By Type, 2017-2031F
  • Figure 120. Brazil Pharmaceutical Gelatin Market Share (%), By Source, 2017-2031F
  • Figure 121. Brazil Pharmaceutical Gelatin Market Share (%), By Application, 2017-2031F
  • Figure 122. Brazil Pharmaceutical Gelatin Market Share (%), By Function, 2017-2031F
  • Figure 123. Brazil Pharmaceutical Gelatin Market Share (%), By End-User, 2017-2031F
  • Figure 124. Argentina Pharmaceutical Gelatin Market, By Value, In USD Billion, 2017-2031F
  • Figure 125. Argentina Pharmaceutical Gelatin Market, By Volume, In Billion Units, 2017-2031F
  • Figure 126. Argentina Pharmaceutical Gelatin Market Share (%), By Type, 2017-2031F
  • Figure 127. Argentina Pharmaceutical Gelatin Market Share (%), By Source, 2017-2031F
  • Figure 128. Argentina Pharmaceutical Gelatin Market Share (%), By Application, 2017-2031F
  • Figure 129. Argentina Pharmaceutical Gelatin Market Share (%), By Function, 2017-2031F
  • Figure 130. Argentina Pharmaceutical Gelatin Market Share (%), By End-User, 2017-2031F
  • Figure 131. Asia-Pacific Pharmaceutical Gelatin Market, By Value, In USD Billion, 2017-2031F
  • Figure 132. Asia-Pacific Pharmaceutical Gelatin Market, By Volume, In Billion Units, 2017-2031F
  • Figure 133. Asia-Pacific Pharmaceutical Gelatin Market Share (%), By Type, 2017-2031F
  • Figure 134. Asia-Pacific Pharmaceutical Gelatin Market Share (%), By Source, 2017-2031F
  • Figure 135. Asia-Pacific Pharmaceutical Gelatin Market Share (%), By Application, 2017-2031F
  • Figure 136. Asia-Pacific Pharmaceutical Gelatin Market Share (%), By Function, 2017-2031F
  • Figure 137. Asia- Pacific Pharmaceutical Gelatin Market Share (%), By End-User, 2017-2031F
  • Figure 138. Asia-Pacific Pharmaceutical Gelatin Market Share (%), By Country, 2017-2031F
  • Figure 139. India Pharmaceutical Gelatin Market, By Value, In USD Billion, 2017-2031F
  • Figure 140. India Pharmaceutical Gelatin Market, By Volume, In Billion Units, 2017-2031F
  • Figure 141. India Pharmaceutical Gelatin Market Share (%), By Type, 2017-2031F
  • Figure 142. India Pharmaceutical Gelatin Market Share (%), By Source, 2017-2031F
  • Figure 143. India Pharmaceutical Gelatin Market Share (%), By Application, 2017-2031F
  • Figure 144. India Pharmaceutical Gelatin Market Share (%), By Function, 2017-2031F
  • Figure 145. India Pharmaceutical Gelatin Market Share (%), By End-User, 2017-2031F
  • Figure 146. China Pharmaceutical Gelatin Market, By Value, In USD Billion, 2017-2031F
  • Figure 147. China Pharmaceutical Gelatin Market, By Volume, In Billion Units, 2017-2031F
  • Figure 148. China Pharmaceutical Gelatin Market Share (%), By Type, 2017-2031F
  • Figure 149. China Pharmaceutical Gelatin Market Share (%), By Source, 2017-2031F
  • Figure 150. China Pharmaceutical Gelatin Market Share (%), By Application, 2017-2031F
  • Figure 151. China Pharmaceutical Gelatin Market Share (%), By Function, 2017-2031F
  • Figure 152. China Pharmaceutical Gelatin Market Share (%), By End-User, 2017-2031F
  • Figure 153. Japan Pharmaceutical Gelatin Market, By Value, In USD Billion, 2017-2031F
  • Figure 154. Japan Pharmaceutical Gelatin Market, By Volume, In Billion Units, 2017-2031F
  • Figure 155. Japan Pharmaceutical Gelatin Market Share (%), By Type, 2017-2031F
  • Figure 156. Japan Pharmaceutical Gelatin Market Share (%), By Source, 2017-2031F
  • Figure 157. Japan Pharmaceutical Gelatin Market Share (%), By Application, 2017-2031F
  • Figure 158. Japan Pharmaceutical Gelatin Market Share (%), By Function, 2017-2031F
  • Figure 159. Japan Pharmaceutical Gelatin Market Share (%), By End-User, 2017-2031F
  • Figure 160. Australia Pharmaceutical Gelatin Market, By Value, In USD Billion, 2017-2031F
  • Figure 161. Australia Pharmaceutical Gelatin Market, By Volume, In Billion Units, 2017-2031F
  • Figure 162. Australia Pharmaceutical Gelatin Market Share (%), By Type, 2017-2031F
  • Figure 163. Australia Pharmaceutical Gelatin Market Share (%), By Source, 2017-2031F
  • Figure 164. Australia Pharmaceutical Gelatin Market Share (%), By Application, 2017-2031F
  • Figure 165. Australia Pharmaceutical Gelatin Market Share (%), By Function, 2017-2031F
  • Figure 166. Australia Pharmaceutical Gelatin Market Share (%), By End-User, 2017-2031F
  • Figure 167. Vietnam Pharmaceutical Gelatin Market, By Value, In USD Billion, 2017-2031F
  • Figure 168. Vietnam Pharmaceutical Gelatin Market, By Volume, In Billion Units, 2017-2031F
  • Figure 169. Vietnam Pharmaceutical Gelatin Market Share (%), By Type, 2017-2031F
  • Figure 170. Vietnam Pharmaceutical Gelatin Market Share (%), By Source, 2017-2031F
  • Figure 171. Vietnam Pharmaceutical Gelatin Market Share (%), By Application, 2017-2031F
  • Figure 172. Vietnam Pharmaceutical Gelatin Market Share (%), By Function, 2017-2031F
  • Figure 173. Vietnam Pharmaceutical Gelatin Market Share (%), By End-User, 2017-2031F
  • Figure 174. South Korea Pharmaceutical Gelatin Market, By Value, In USD Billion, 2017-2031F
  • Figure 175. South Korea Pharmaceutical Gelatin Market, By Volume, In Billion Units, 2017-2031F
  • Figure 176. South Korea Pharmaceutical Gelatin Market Share (%), By Type, 2017-2031F
  • Figure 177. South Korea Pharmaceutical Gelatin Market Share (%), By Source, 2017-2031F
  • Figure 178. South Korea Pharmaceutical Gelatin Market Share (%), By Application, 2017-2031F
  • Figure 179. South Korea Pharmaceutical Gelatin Market Share (%), By Function, 2017-2031F
  • Figure 180. South Korea Pharmaceutical Gelatin Market Share (%), By End-User, 2017-2031F
  • Figure 181. Indonesia Pharmaceutical Gelatin Market, By Value, In USD Billion, 2017-2031F
  • Figure 182. Indonesia Pharmaceutical Gelatin Market, By Volume, In Billion Units, 2017-2031F
  • Figure 183. Indonesia Pharmaceutical Gelatin Market Share (%), By Type, 2017-2031F
  • Figure 184. Indonesia Pharmaceutical Gelatin Market Share (%), By Source, 2017-2031F
  • Figure 185. Indonesia Pharmaceutical Gelatin Market Share (%), By Application, 2017-2031F
  • Figure 186. Indonesia Pharmaceutical Gelatin Market Share (%), By Function, 2017-2031F
  • Figure 187. Indonesia Pharmaceutical Gelatin Market Share (%), By End-User, 2017-2031F
  • Figure 188. Philippines Pharmaceutical Gelatin Market, By Value, In USD Billion, 2017-2031F
  • Figure 189. Philippines Pharmaceutical Gelatin Market, By Volume, In Billion Units, 2017-2031F
  • Figure 190. Philippines Pharmaceutical Gelatin Market Share (%), By Type, 2017-2031F
  • Figure 191. Philippines Pharmaceutical Gelatin Market Share (%), By Source, 2017-2031F
  • Figure 192. Philippines Pharmaceutical Gelatin Market Share (%), By Application, 2017-2031F
  • Figure 193. Philippines Pharmaceutical Gelatin Market Share (%), By Function, 2017-2031F
  • Figure 194. Philippines Pharmaceutical Gelatin Market Share (%), By End-User, 2017-2031F
  • Figure 195. Middle East & Africa Pharmaceutical Gelatin Market, By Value, In USD Billion, 2017-2031F
  • Figure 196. Middle East & Africa Pharmaceutical Gelatin Market, By Volume, In Billion Units, 2017-2031F
  • Figure 197. Middle East & Africa Pharmaceutical Gelatin Market Share (%), By Type, 2017-2031F
  • Figure 198. Middle East & Africa Pharmaceutical Gelatin Market Share (%), By Source, 2017-2031F
  • Figure 199. Middle East & Africa Pharmaceutical Gelatin Market Share (%), By Application, 2017-2031F
  • Figure 200. Middle East & Africa Pharmaceutical Gelatin Market Share (%), By Function, 2017-2031F
  • Figure 201. Middle East & Africa Pharmaceutical Gelatin Market Share (%), By End-User, 2017-2031F
  • Figure 202. Middle East & Africa Pharmaceutical Gelatin Market Share (%), By Country, 2017-2031F
  • Figure 203. Saudi Arabia Pharmaceutical Gelatin Market, By Value, In USD Billion, 2017-2031F
  • Figure 204. Saudi Arabia Pharmaceutical Gelatin Market, By Volume, In Billion Units, 2017-2031F
  • Figure 205. Saudi Arabia Pharmaceutical Gelatin Market Share (%), By Type, 2017-2031F
  • Figure 206. Saudi Arabia Pharmaceutical Gelatin Market Share (%), By Source, 2017-2031F
  • Figure 207. Saudi Arabia Pharmaceutical Gelatin Market Share (%), By Application, 2017-2031F
  • Figure 208. Saudi Arabia Pharmaceutical Gelatin Market Share (%), By Function, 2017-2031F
  • Figure 209. Saudi Arabia Pharmaceutical Gelatin Market Share (%), By End-User, 2017-2031F
  • Figure 210. UAE Pharmaceutical Gelatin Market, By Value, In USD Billion, 2017-2031F
  • Figure 211. UAE Pharmaceutical Gelatin Market, By Volume, In Billion Units, 2017-2031F
  • Figure 212. UAE Pharmaceutical Gelatin Market Share (%), By Type, 2017-2031F
  • Figure 213. UAE Pharmaceutical Gelatin Market Share (%), By Source, 2017-2031F
  • Figure 214. UAE Pharmaceutical Gelatin Market Share (%), By Application, 2017-2031F
  • Figure 215. UAE Pharmaceutical Gelatin Market Share (%), By Function, 2017-2031F
  • Figure 216. UAE Pharmaceutical Gelatin Market Share (%), By End-User, 2017-2031F
  • Figure 217. South Africa Pharmaceutical Gelatin Market, By Value, In USD Billion, 2017-2031F
  • Figure 218. South Africa Pharmaceutical Gelatin Market, By Volume, In Billion Units, 2017-2031F
  • Figure 219. South Africa Pharmaceutical Gelatin Market Share (%), By Type, 2017-2031F
  • Figure 220. South Africa Pharmaceutical Gelatin Market Share (%), By Source, 2017-2031F
  • Figure 221. South Africa Pharmaceutical Gelatin Market Share (%), By Application, 2017-2031F
  • Figure 222. South Africa Pharmaceutical Gelatin Market Share (%), By Function, 2017-2031F
  • Figure 223. South Africa Pharmaceutical Gelatin Market Share (%), By End-User, 2017-2031F
  • Figure 224. By Type Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 225. By Source Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 226. By Application Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 227. By Function Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 228. By End-User Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 229. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2023